These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10089626)

  • 1. [Radical prostatectomy. The surgical complications].
    Martín-Marquina Aspiunza A; Zudaire Bergera JJ; Sánchez Zalabardo D; Arocena García-Tapia J; Sanz Pérez G; Díez-Caballero Alonso F; Rosell Costa D; Robles García JE; Berián Polo JM
    Actas Urol Esp; 1999 Jan; 23(1):5-9. PubMed ID: 10089626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and complications of radical prostatectomy in patients with PSA <10 ng/ml: comparison between the retropubic, perineal and laparoscopic approach.
    Salomon L; Levrel O; Anastasiadis AG; Saint F; de La Taille A; Cicco A; Vordos D; Hoznek A; Chopin D; Abbou CC
    Prostate Cancer Prostatic Dis; 2002; 5(4):285-90. PubMed ID: 12627213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The complications of retropubic radical prostatectomy].
    Abad Vivas-Pérez JI; Rodríguez-Rubio Cortadellas FI; Martín-Marquina Aspiunza A; Díez-Caballero Alonso F; Rosell Costa D; Robles García JE; Zudaire Bergera JJ; Berián Polo JM
    Actas Urol Esp; 1997 Apr; 21(4):357-60. PubMed ID: 9265407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The morbidity of radical prostatectomy using a retropubic approach: a series of 150 cases].
    Bretheau D; Bochereau G; Veillon B; Brisset JM; Vallancien G
    Prog Urol; 1994; 4(4):523-31. PubMed ID: 7920728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program.
    Varkarakis J; Pinggera GM; Sebe P; Berger A; Bartsch G; Horninger W
    Urology; 2004 Feb; 63(2):337-41. PubMed ID: 14972485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.
    Gonzalez CM; Roehl KA; Antenor JV; Blunt LW; Han M; Catalona WJ
    Urology; 2004 Oct; 64(4):723-8. PubMed ID: 15491709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.
    Fair WR; Betancourt JE
    Mol Urol; 2000; 4(3):241-8;discussion 249-50. PubMed ID: 11062380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
    J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
    Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radical transcoccygeal prostatectomy].
    Rigatti P; Francesca F; Da Pozzo LF; Bocciardi A; Spaliviero M; Bua L
    Chir Ital; 1996; 48(5):9-20. PubMed ID: 9206618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years.
    Amling CL; Blute ML; Bergstralh EJ; Seay TM; Slezak J; Zincke H
    J Urol; 2000 Jul; 164(1):101-5. PubMed ID: 10840432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques.
    Krambeck AE; DiMarco DS; Rangel LJ; Bergstralh EJ; Myers RP; Blute ML; Gettman MT
    BJU Int; 2009 Feb; 103(4):448-53. PubMed ID: 18778350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical results of radical prostatectomy for patients with prostate cancer in Macau.
    Ho SF; Lao HF; Li K; Tse MK
    Chin Med J (Engl); 2008 Feb; 121(4):295-8. PubMed ID: 18304459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term follow-up of radical retropubic prostatectomy for prostate cancer in 400 consecutive patients].
    Stav K; Sandbank J; Shilo Y; Lindner A; Zisman A
    Harefuah; 2005 Sep; 144(9):602-4, 680. PubMed ID: 16218526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy.
    Alessandro S; Vincenzo G; Maria AG; Stefano S; Alessandro G; Salvatore M; Vincenzo T; Franco DS
    Endocr Relat Cancer; 2007 Sep; 14(3):625-32. PubMed ID: 17914093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.